The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
5,852
Sort by:
Global Artificial Intelligence in Drug Discovery Market Size Study, by Application (Drug Optimization and Repurposing, Preclinical Testing, Others), by Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Others), and Regional Forecasts 2022-2032
US$ 3,218.00
The Global Artificial Intelligence (AI) in Drug Discovery Market was valued at approximately USD 1.6 billion in 2023 and is projected to expand at a robust CAGR of 29.7% during the forecast period 202...
January 2025
285 pages
Global Post-traumatic Stress Disorder Treatment Market Size study, by Drug Class (Antidepressants, Anti-anxiety, Antipsychotics, Other Drug Class), by Demographics (Adult, Children, Geriatric), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Other Pharmacies) and Regional Forecasts 2022-2032
US$ 3,218.00
The global post-traumatic stress disorder (PTSD) treatment market was valued at USD 2.14 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.08% over the forecast p...
January 2025
285 pages
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
US$ 2,999.00
The global congestive heart failure drugs market size reached USD 9.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24.5 Billion by 2033, exhibiting a growth rate (CAGR...
January 2025
134 pages
Duchenne Muscular Dystrophy Drugs Market by Product Type (Corticosteroids, Pain Management Drugs), Therapeutic Approach (Mutation Suppression, Exon Skipping, Steroid Therapy), End User (Hospitals, Clinics, Home Care Settings), and Region 2025-2033
US$ 2,999.00
The global Duchenne muscular dystrophy drugs market size reached USD 2.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.9 Billion by 2033, exhibiting a growth rate (CA...
January 2025
143 pages
Immune Checkpoint Inhibitors Market Report by Type (CTLA-4 Inhibitor, PD-1 Inhibitor, PD-L1 Inhibitor), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Lung Cancer, Bladder Cancer, Melanoma, Colorectal Cancer, Hodgkin Lymphoma, and Others), and Region 2025-2033
US$ 2,999.00
The global immune checkpoint inhibitors market size reached USD 49.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 168.6 Billion by 2033, exhibiting a growth rate (CAGR...
January 2025
124 pages
Dementia Drugs Market by Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others), Drug Class (Cholinesterase Inhibitors, NMDA Antagonists and its Combination Drugs), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), and Region 2025-2033
US$ 2,999.00
The global dementia drugs market size reached USD 19.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 35.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.9% durin...
January 2025
134 pages
Gastric Cancer Drugs Market Report by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2025-2033
US$ 2,999.00
The global gastric cancer drugs market size reached USD 5.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.5 Billion by 2033, exhibiting a growth rate (CAGR) of 10.7%...
January 2025
135 pages
Hyperphosphatemia Drugs Market Report by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
US$ 2,999.00
The global hyperphosphatemia drugs market size reached USD 4.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.7...
January 2025
137 pages
Peptic Ulcer Drugs Market by Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2-Antagonists, Antibiotics, Ulcer protective), Ulcer Type (Gastric Ulcer, Duodenal Ulcer, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
US$ 2,999.00
The global peptic ulcer drugs market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.2 Billion by 2033, exhibiting a growth rate (CAGR) of 2.51% du...
January 2025
135 pages
Global Age-related Macular Degeneration (AMD) Drugs Market Size Study, by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), by Molecule (Ranibizumab, Aflibercept, Faricimab), by Approval Type (Biologic, Biosimilar), by Type of AMD, and Regional Forecasts 2022-2032
US$ 3,218.00
The Global Age-related Macular Degeneration (AMD) Drugs Market is currently valued at approximately USD 9.45 billion in 2023 and is forecasted to grow at an impressive CAGR of 10.70% over the forecast...
January 2025
285 pages
OTC Drugs, Medical Devices and Diagnostics: Global Markets
US$ 4,650.00
Report : The current report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics...
January 2025
139 pages
Global Antiplatelet Market: Analysis By Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other Drug Classes), By Route of Administration (Oral and Injectable), By Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,250.00
Antiplatelet drugs prevent platelets from sticking together and decrease the body’s ability to form blood clots. These medications are used to treat, and may help prevent, heart attack, abnormal heart...
November 2024
146 pages
Prescription Drugs Markets in China
US$ 4,000.00
China's demand for Prescription Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
October 2024
217 pages
Prescription Drugs Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Prescription Drugs industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
October 2024
93 pages
Prescription Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Prescription Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
October 2024
73 pages
International Trade in Activated Carbon: Trends and Prospects
US$ 820.00
The reports examine global activated carbon market trends (historical, current and forecast) with respect to international trade including activated carbon global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Alkaloids, Derivs, no Antibiotics, Hormones, in Dosage: Trends and Prospects
US$ 820.00
The reports examine global alkaloids, derivs, no antibiotics, hormones, in dosage market trends (historical, current and forecast) with respect to international trade including alkaloids, derivs, no antibiotics, hormones, in dosage global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Alkaloids, Derivs, Without Antibiotics, Hormones, Bulk: Trends and Prospects
US$ 820.00
The reports examine global alkaloids, derivs, without antibiotics, hormones, bulk market trends (historical, current and forecast) with respect to international trade including alkaloids, derivs, without antibiotics, hormones, bulk global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Antibiotics: Trends and Prospects
US$ 820.00
The reports examine global antibiotics market trends (historical, current and forecast) with respect to international trade including antibiotics global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Antibiotics Nes, Formulated, in Bulk: Trends and Prospects
US$ 820.00
The reports examine global antibiotics nes, formulated, in bulk market trends (historical, current and forecast) with respect to international trade including antibiotics nes, formulated, in bulk global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Antibiotics Nes, in Dosage: Trends and Prospects
US$ 820.00
The reports examine global antibiotics nes, in dosage market trends (historical, current and forecast) with respect to international trade including antibiotics nes, in dosage global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Disinfectants: Trends and Prospects
US$ 820.00
The reports examine global disinfectants market trends (historical, current and forecast) with respect to international trade including disinfectants global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Erythromycin and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global erythromycin and its derivatives market trends (historical, current and forecast) with respect to international trade including erythromycin and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Glands and Other Organs, Dried, for Therapeutic Uses: Trends and Prospects
US$ 820.00
The reports examine global glands and other organs, dried, for therapeutic uses market trends (historical, current and forecast) with respect to international trade including glands and other organs, dried, for therapeutic uses global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Hormones Nes, Except Contraceptives, in Dosage: Trends and Prospects
US$ 820.00
The reports examine global hormones nes, except contraceptives, in dosage market trends (historical, current and forecast) with respect to international trade including hormones nes, except contraceptives, in dosage global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Hormones Nes, no Antibiotics, Bulk, not Contraceptive: Trends and Prospects
US$ 820.00
The reports examine global hormones nes, no antibiotics, bulk, not contraceptive market trends (historical, current and forecast) with respect to international trade including hormones nes, no antibiotics, bulk, not contraceptive global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Insulin, Formulated, in Bulk: Trends and Prospects
US$ 820.00
The reports examine global insulin, formulated, in bulk market trends (historical, current and forecast) with respect to international trade including insulin, formulated, in bulk global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Insulin, in Dosage: Trends and Prospects
US$ 820.00
The reports examine global insulin, in dosage market trends (historical, current and forecast) with respect to international trade including insulin, in dosage global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Penicillins and Streptomycins, Derivs, in Dosage: Trends and Prospects
US$ 820.00
The reports examine global penicillins and streptomycins, derivs, in dosage market trends (historical, current and forecast) with respect to international trade including penicillins and streptomycins, derivs, in dosage global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Streptomycins and Their Derivatives: Trends and Prospects
US$ 820.00
The reports examine global streptomycins and their derivatives market trends (historical, current and forecast) with respect to international trade including streptomycins and their derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Tetracyclines and Their Derivatives: Trends and Prospects
US$ 820.00
The reports examine global tetracyclines and their derivatives market trends (historical, current and forecast) with respect to international trade including tetracyclines and their derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Tetrahydrocannabinols (all Isomers): Trends and Prospects
US$ 820.00
The reports examine global tetrahydrocannabinols (all isomers) market trends (historical, current and forecast) with respect to international trade including tetrahydrocannabinols (all isomers) global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Vitamin B1 and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global vitamin b1 and its derivatives market trends (historical, current and forecast) with respect to international trade including vitamin b1 and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Vitamin B12 and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global vitamin b12 and its derivatives market trends (historical, current and forecast) with respect to international trade including vitamin b12 and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Vitamin B2 and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global vitamin b2 and its derivatives market trends (historical, current and forecast) with respect to international trade including vitamin b2 and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Vitamin B6 and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global vitamin b6 and its derivatives market trends (historical, current and forecast) with respect to international trade including vitamin b6 and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Vitamin C and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global vitamin c and its derivatives market trends (historical, current and forecast) with respect to international trade including vitamin c and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Vitamin E and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global vitamin e and its derivatives market trends (historical, current and forecast) with respect to international trade including vitamin e and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
